Another article and interview video has been published recently about the Berlin Patient. The Berlin Patient is the only individual who has been cured of HIV. The process for affecting that cure is described here.
Since Sangamo (SGMO) is the only company that can replicate that process in a manner that does not require an onerous and life threatening procedure, there will be new and increased interest in the company, its scientists, their drugs and technologies.
In a previous article I laid out the rationale for why Sangamo BioScience was a must-have acquisition for all of the large pharmaceuticals. With this eventuality all but certain, I went looking for companies that had previously been acquired at the same stage in their development efforts, and offered similar platform technologies for comparison to Sangamo. Sirtris Pharmaceuticals was almost an exact match.
In April of 2008 Glaxo Smith Kline (GSK) bought out Sirtris
Complete Story »
No comments:
Post a Comment